A Case Report of Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination and Heparin Use During Hemodialysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Son, Young-Bin | - |
dc.contributor.author | Kim, Tae-Bum | - |
dc.contributor.author | Min, Hyeon-Jin | - |
dc.contributor.author | Lee, Jonghyun | - |
dc.contributor.author | Yang, Jihyun | - |
dc.contributor.author | Kim, Myung-Gyu | - |
dc.contributor.author | Jo, Sang Kyung | - |
dc.contributor.author | Cho, Won Yong | - |
dc.contributor.author | Oh, Se Won | - |
dc.date.accessioned | 2022-05-09T13:42:23Z | - |
dc.date.available | 2022-05-09T13:42:23Z | - |
dc.date.created | 2022-05-09 | - |
dc.date.issued | 2022-03-14 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/140838 | - |
dc.description.abstract | Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but life-threatening complication. VITT strongly mimics heparin-induced thrombocytopenia (HIT) and shares clinical features. Heparin is commonly used to prevent coagulation during hemodialysis. Therefore, nephrologists might encounter patients needing dialysis with a history of heparin exposure who developed thrombotic thrombocytopenia after vaccination. A 70-year-old male presented with acute kidney injury and altered mental status due to lithium intoxication. He needed consecutive hemodialysis using heparin. Deep vein thrombosis of left lower extremity and accompanying severe thrombocytopenia of 15,000/mu L on 24 days after vaccination and at the same time, nine days after heparin use. Anti-platelet factor 4 antibody test was positive. Anticoagulation with apixaban and intravenous immunoglobulin (IVIG) infusion resolved swelling of his left calf and thrombocytopenia. There were no definitive diagnostic tools capable of differentiating between VITT and HIT in this patient. Although VITT and HIT share treatment with IVIG and non-heparin anticoagulation, distinguishing between VITT and HIT will make it possible to establish a follow-up vaccination plan in a person who has had a thrombocytopenic thrombotic event. Further research is needed to develop the tools to make a clear distinction between the clinical syndromes. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.title | A Case Report of Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination and Heparin Use During Hemodialysis | - |
dc.title.alternative | A Case Report of Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination and Heparin Use During Hemodialysis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Myung-Gyu | - |
dc.identifier.doi | 10.3346/jkms.2022.37.e75 | - |
dc.identifier.scopusid | 2-s2.0-85126717715 | - |
dc.identifier.wosid | 000771092100002 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.37, no.10, pp.1 - 6 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 37 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 6 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002820458 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordAuthor | Anti-Platelet Factor 4 Antibody | - |
dc.subject.keywordAuthor | ChAdOx1 COVID-19 Vaccine | - |
dc.subject.keywordAuthor | Heparin | - |
dc.subject.keywordAuthor | Thrombotic Thrombocytopenia | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.